OTTAWA (Reuters) – Canada has not received a request to approve a booster shot of the Pfizer and BioNTech COVID-19 vaccine, and it is currently studying the vaccine’s duration of protection, the Health Ministry said in a statement on Friday.
“Health Canada has not received a submission from Pfizer for the approval of a COVID-19 booster shot. Should a submission be received, Health Canada will evaluate the data provided,” the statement said.
“The duration of protection from one or two doses of COVID-19 vaccines is currently being studied.”
(Reporting by Steve Scherer; Editing by Leslie Adler)
